Idiopathic focal segmental glomerulosclerosis

Indian Pediatrics

Volumn 47, Issue 6, 2010, Pages 507-510

  Naseri, Mitra ^a,b   Madani, Abbas ^a,b   Attaii, Nematolah ^a,b   Naseri, Homa ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Focal segmental glomerculosclerosis; Iran; Nephrotic syndrome; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISOLONE; PREDNISONE; STEROID;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; KIDNEY FIBROSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; THERAPY EFFECT; ADOLESCENT; CHI SQUARE DISTRIBUTION; CHILD; INFANT; IRAN; KAPLAN MEIER METHOD; NEPHROTIC SYNDROME; NONPARAMETRIC TEST; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INFANT; IRAN; KAPLAN-MEIERS ESTIMATE; MALE; NEPHROTIC SYNDROME; PREVALENCE; STATISTICS, NONPARAMETRIC; STEROIDS; TREATMENT OUTCOME;

EID: 78049384945     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: 10.1007/s13312-010-0091-5     Document Type: Article

References (13)

1. th edn. Philadelphia: Elsevier Saunders; 2005. p. 955-1021.
2. th edn. Philadelphia: Williams and Wilkins; 2004. 557-573.
3. Y. Frishberg C. Rinat O. Megged E. Shapira S. Feinstein A. Raas-Rothschild 2002 Mutations in NPHS2 encoding podocin is a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children J Am Soc Nephrol 13 400 405 1:CAS:528:DC%2BD38XhtlWju7w%3D 11805168
4. th edn. Philadelphia: Williams and Wilkins; 2004. p. 399-424
5. th edn. Philadelphia: Williams and Wilkins; 2004. p. 1125-1151.
6. A. Levin 2003 The advantages of a uniform terminology and staging system for chronic kidney disease (CKD) Nephrol Dial Transplant 18 1446 1451 10.1093/ndt/gfg241 12897079
7. D. Ostalska-Nowicka J. Zachwieja J. Maciejewski A. WoYniak W. Salwa-Urawska 2004 The prognostic value of glomerular immaturity in the nephrotic syndrome in children Pediatr Nephrol 19 633 637 10.1007/s00467-004- 1449-5 15071770
8. M. Morita R.H. White N.A. Coad F. Raafat 1990 The clinical significance of the glomerular location of segmental lesions in focal segmental glomerulosclerosis Clin Nephrol 33 211 219 1:STN:280:DyaK3c3osVWitg%3D%3D 2354557
9. D.S. Gipson H. Chin T.P. Presler C. Jennette M.E. Ferris S. Massengill, et al. 2006 Differential risk of remission and ESRD in childhood FSGS Pediatr Nephrol 21 344 349 10.1007/s00467-005-2097-0 16395603
10. D.F. Geary M. Farine P. Thorner R. Baumal 1984 Response to cyclophosphamide in steroidresistant focal segmental glomerulosclerosis: a reappraisal Clin Nephrol 22 109 113 1:STN:280:DyaL2M%2FisFGmsw%3D%3D 6488594
11. A.S. Abeyagunawardena N.J. Sebire R.A. Risdon M.J. Dillon L. Rees W. Van't Hoff, et al. 2007 Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis Pediatr Nephrol 22 215 221 10.1007/s00467-006-0264-6 17146670
12. K.H. Paik B.H. Lee H.Y. Cho H.G. Kang I.S. Ha H.I. Cheong, et al. 2007 Primary focal segmental glomerular sclerosis in children: clinical course and prognosis Pediatr Nephrol 22 389 395 10.1007/s00467-006-0301-5 17058050
13. P. Tarshish J.N. Tobin J. Bernstein C.M. Edelmann Jr. 1996 Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children Pediatr Nephrol 10 590 593 1:STN:280:DyaK2s%2Flt12gsQ%3D%3D 10.1007/s004670050167 8897562